Literature DB >> 8782485

p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines.

K Servomaa1, A Kiuru, R Grénman, K Pekkola-Heino, J O Pulkkinen, T Rytömaa.   

Abstract

The p53 tumour suppressor gene is activated following cellular exposure to DNA-damaging agents. The functions of wild-type p53 protein include transient blocking of cell cycle progression, direct or indirect stimulation of DNA repair machinery and triggering of apoptosis if DNA repair fails. Therefore, the status of p53 protein may be critically associated with tumour cell radiosensitivity. In the present study we examine the intrinsic radiosensitivity of 20 human carcinoma cell lines derived from 15 patients with different types of head and neck tumour. Radiosensitivities were measured in a 96-well plate clonogenic assay in terms of the mean inactivation dose, surviving fraction at 2 Gy, and constants alpha and beta in the linear quadratic survival curve. The p53 allele status was determined by amplifying exons 4-10 by the polymerase chain reaction (PCR), screening for mutations using single-strand conformation polymorphism (SSCP) analysis and determining the exact type and location of a mutation by direct sequencing. The results showed that prevalence of p53 mutations in squamous cell carcinoma (SCC) cell lines is high (80%), and that deletion of one or both wild-type alleles is common (75%). Intrinsic radiosensitivity of the cell lines varied greatly in terms of mean inactivation dose, from 1.4 +/- 0.1 to 2.6 +/- 0.2 Gy. Radiosensitivity correlated well with the p53 allele status so that cell lines carrying a wild-type p53 allele were significantly (P < 0.01) more radioresistant (mean inactivation dose 2.23 +/- 0.15 Gy) than cell lines which lacked a wild-type gene (1.82 +/- 0.24 Gy). Evaluation of our own results and those published in the literature lead us to conclude that absence of the wild-type p53 allele in human head and neck cancer cell lines is associated with increased radiosensitivity. However, the sensitivity is also strongly dependent on the exact type and location of the p53 mutation.

Entities:  

Mesh:

Year:  1996        PMID: 8782485     DOI: 10.1046/j.1365-2184.1996.01009.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  11 in total

Review 1.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

2.  p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women.

Authors:  K Servomaa; A Kiuru; V M Kosma; P Hirvikoski; T Rytömaa
Journal:  Mol Pathol       Date:  2000-02

3.  Targeting p53 for Novel Anticancer Therapy.

Authors:  Zhen Wang; Yi Sun
Journal:  Transl Oncol       Date:  2010-02       Impact factor: 4.243

4.  Effect of ionizing radiation on the physical biology of head and neck squamous cell carcinoma cells.

Authors:  Sandra M Baker-Groberg; Sophia Bornstein; Jevgenia Zilberman-Rudenko; Mark Schmidt; Garth W Tormoen; Casey Kernan; Charles R Thomas; Melissa H Wong; Kevin G Phillips; Owen J T McCarty
Journal:  Cell Mol Bioeng       Date:  2015-05-07       Impact factor: 2.321

5.  Lysosomal trapping of palbociclib and its functional implications.

Authors:  Susana Llanos; Diego Megias; Carmen Blanco-Aparicio; Elena Hernández-Encinas; Miguel Rovira; Federico Pietrocola; Manuel Serrano
Journal:  Oncogene       Date:  2019-01-28       Impact factor: 9.867

6.  Assessing Various Control Samples for Microarray Gene Expression Profiling of Laryngeal Squamous Cell Carcinoma.

Authors:  Adam Ustaszewski; Magdalena Kostrzewska-Poczekaj; Joanna Janiszewska; Malgorzata Jarmuz-Szymczak; Malgorzata Wierzbicka; Joanna Marszal; Reidar Grénman; Maciej Giefing
Journal:  Biomolecules       Date:  2021-04-16

7.  Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers.

Authors:  Susana Llanos; Juana M García-Pedrero; Lucia Morgado-Palacin; Juan P Rodrigo; Manuel Serrano
Journal:  Nat Commun       Date:  2016-02-02       Impact factor: 14.919

8.  Intricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation.

Authors:  Ana T Pinto; Marta L Pinto; Sérgia Velho; Marta T Pinto; Ana P Cardoso; Rita Figueira; Armanda Monteiro; Margarida Marques; Raquel Seruca; Mário A Barbosa; Marc Mareel; Maria J Oliveira; Sónia Rocha
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

9.  Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines.

Authors:  Eva-Leonne Göttgens; Marleen Ansems; William P J Leenders; Johan Bussink; Paul N Span
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.639

10.  Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.

Authors:  Johannes Routila; Karri Suvila; Reidar Grénman; Ilmo Leivo; Jukka Westermarck; Sami Ventelä
Journal:  BMC Cancer       Date:  2021-07-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.